Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects.
Vale ECSD, Garcia LC.
An Bras Dermatol. 2023 May-Jun;98(3):355-372. doi: 10.1016/j.abd.2022.09.005. Epub 2023 Mar 1.
Subacute cutaneous lupus erythematosus: A facultative paraneoplastic dermatosis.
Lazar AL.
Clin Dermatol. 2022 Nov-Dec;40(6):728-742. doi: 10.1016/j.clindermatol.2022.07.007. Epub 2022 Jul 28.
Cutaneous lupus erythematosus: diagnosis and treatment.
Okon LG, Werth VP.
Best Pract Res Clin Rheumatol. 2013 Jun;27(3):391-404. doi: 10.1016/j.berh.2013.07.008.
Cutaneous lupus erythematosus: issues in diagnosis and treatment.
Walling HW, Sontheimer RD.
Am J Clin Dermatol. 2009;10(6):365-81. doi: 10.2165/11310780-000000000-00000.
Drug-induced lupus erythematosus: an update on drugs and mechanisms.
He Y, Sawalha AH.
Curr Opin Rheumatol. 2018 Sep;30(5):490-497. doi: 10.1097/BOR.0000000000000522.
Ethambutol-induced subacute cutaneous lupus erythematosus.
Huang YW, Wu WH.
Kaohsiung J Med Sci. 2022 Sep;38(9):914-915. doi: 10.1002/kjm2.12571. Epub 2022 Jun 29.
New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
Zhou W, Wu H, Zhao M, Lu Q.
Expert Rev Clin Immunol. 2020 Aug;16(8):829-837. doi: 10.1080/1744666X.2020.1805316. Epub 2020 Sep 29.
Subacute cutaneous lupus erythematosus after COVID-19 vaccine.
Wang YJ, Hui HZ, Cheng JR, Mao H, Shi BJ.
Int J Rheum Dis. 2023 Jul;26(7):1407-1409. doi: 10.1111/1756-185X.14640. Epub 2023 Mar 7.
Secukinumab-induced subacute cutaneous lupus erythematosus.
Conforti C, Retrosi C, Giuffrida R, Vezzoni R, Currado D, Navarini L, Farinazzo E, Dell'Aquila C, Nan K, Di Meo N, Zalaudek I.
Dermatol Ther. 2020 May;33(3):e13417. doi: 10.1111/dth.13417. Epub 2020 May 3.
Radiation-induced subacute cutaneous lupus erythematosus.
De Caux D, Kelly Á, Pearce J, Natkunarajah J.
Clin Exp Dermatol. 2022 Jun;47(6):1184-1185. doi: 10.1111/ced.15099. Epub 2022 Mar 14.
